Dow Up0.48% Nasdaq Up0.43%

Sanofi (SNY)

-NYSE
53.29 0.15(0.28%) Aug 19, 4:02PM EDT
|Pre-Market : 52.83 Down 0.46 (0.86%) 7:17AM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 45,894,000   47,406,000   45,511,000  
Cost of Revenue15,144,000  14,632,000  14,105,000  
Gross Profit 30,751,000   32,774,000   31,406,000  
Operating Expenses
Research Development6,573,000  6,467,000  6,216,000  
Selling General and Administrative10,801,000  11,830,000  10,965,000  
Non Recurring2,325,000  1,659,000  2,314,000  
Others4,015,000  4,339,000  4,302,000  
Total Operating Expenses23,714,000  24,295,000  23,797,000  
Operating Income or Loss 7,036,000   8,480,000   7,609,000  
Income from Continuing Operations
Total Other Income/Expenses Net150,000  123,000  182,000  
Earnings Before Interest And Taxes7,186,000  8,602,000  7,790,000  
Interest Expense843,000  990,000  966,000  
Income Before Tax6,343,000  7,612,000  6,824,000  
Income Tax Expense1,051,000  1,462,000  571,000  
Minority Interest(218,000)(223,000)(313,000)
Net Income From Continuing Ops5,122,000  6,446,000  7,329,000  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 5,122,000   6,446,000   7,329,000  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 5,122,000   6,446,000   7,329,000  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.